Evidence map›Paper›PMID 41063832›Full record

ReviewFrontiers in cardiovascular medicine2025

Pulsed field ablation for atrial fibrillation: clinical applications and research advances.

Meng Sun, XiaoHong Fu, Jia Gao, Min Guo, Wenjie Yin, Rui Wang

Abstract readReview
In one paragraph

Review in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Meng SunDepartment of Cardiology, First Hospital of Shanxi Medical University, Taiyuan, China.
XiaoHong FuDepartment of Cardiology, First Hospital of Shanxi Medical University, Taiyuan, China.
Jia GaoDepartment of Cardiology, First Hospital of Shanxi Medical University, Taiyuan, China.
Min GuoDepartment of Cardiology, First Hospital of Shanxi Medical University, Taiyuan, China.
Wenjie YinDepartment of Cardiology, First Hospital of Shanxi Medical University, Taiyuan, China.
Rui WangDepartment of Cardiology, First Hospital of Shanxi Medical University, Taiyuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, associated with increased risks of stroke, heart failure, and mortality. With the advancement of catheter ablation technology, pulsed field ablation (PFA), a novel nonthermal ablation modality, has garnered growing attention due to its myocardial selectivity and favorable safety profile. This review systematically summarizes the biophysical principles, clinical advantages, catheter systems, special population applications, limitations, and future directions of PFA based on the latest evidence.

Indexed as

atrial fibrillationemerging technologiesirreversible electroporationmyocardial selectivitypulmonary vein isolationpulsed field ablationsafety

Identifiers

PMID41063832
PMCPMC12500624

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.